Reducing antibiotic burden in gram-negative bacteraemia: duration optimization and early oral transition.

Authors

Renato Pascale, Matteo Montironi, Maddalena Giannella

Published in

Current opinion in infectious diseases. Oct 12, 2026. Epub Oct 12, 2026.

Abstract

Gram-negative bloodstream infections have traditionally been managed with prolonged and intravenous antibiotic therapy. This review aims to summarize the evidence supporting strategies to reduce antibiotic burden through shorter treatment durations and/or oral step-down therapy.
Recent randomized controlled trials, target trial emulations, and large observational studies demonstrate that in patients with uncomplicated Gram-negative bloodstream infections an early oral step-down therapy and/or reduced antibiotic courses achieve clinical outcomes comparable to prolonged intravenous therapy and longer treatment durations. Fluoroquinolones and trimethoprim-sulfamethoxazole remain the preferred oral agents because of their high bioavailability. Appropriately dosed oral β-lactams appear to provide comparable outcomes, highlighting the importance of exposure optimization rather than antibiotic class alone. The evidence is expanding also for special populations, but important knowledge gaps remain for patients with severe immunosuppression and multidrug-resistant pathogens.
Current evidence supports reducing antibiotic exposure in selected patients with Gram-negative bloodstream infections by combining shorter treatment durations and early oral step-down therapy. Future studies should address remaining evidence gaps, particularly in frail patients.

PMID:
42859849
Bibliographic data and abstract were imported from PubMed on 11 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.